AI Chat
Macro & News
Stocks
Alpha Lab
Utility
Menu
EN
Login
EN
Surge Analysis
/
U2Bio Co., Ltd.
/
2026-04-23
▲ SURGE
U2Bio Co., Ltd.
+17.3%
221800
KRX
Healthcare
2026-04-23
18,300
Close
15,600
Prev Close
+17.31%
Change
12.8x
Vol Ratio
Why It Surged
No related news available.
Related News
Uni-Bio Science to Update Articles for New HK Listing and Market Regimes
Tipranks
2026-03-27
New May data will show verekitug effects in nasal polyp patients
Stocktitan
2026-04-17
Unico Silver Grants Additional Performance Rights to Director Peter Canterbury
Tipranks
2026-04-08
Upstream Bio to Present New Data from Phase 2 VIBRANT Trial of Verekitug at the ATS 2026 International Conference
Au.Marketscreener
2026-04-17
iBio Q2 EPS $(0.09) Misses $(0.07) Estimate - iBio (NASDAQ:IBIO)
Benzinga
2026-02-10
Technical Analysis
Signals
MACD Bearish
Below SMA20
Key Indicators
50.38
RSI (14)
18670.00
SMA 20
14162.20
Bollinger Lower
23177.80
Bollinger Upper
18670.00
Bollinger Mid
-754.90
MACD
-576.00
MACD Signal
-178.90
MACD Hist
View Company
Back to Surge Stocks
U2Bio Co., Ltd. Surged +17.3% on 2026-04-23 — Analysis | Alpha Lenz